The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced the launch of an essay competition dedicated to patient safety as part of the annual MedSafetyWeek 2026 campaign. The initiative aims to draw public attention to the monitoring of adverse effects of medicines and medical devices. As part of the campaign, MHRA once again calls on patients, their parents, carers, and healthcare professionals to report any suspected adverse effects of medicines through the national Yellow Card reporting system. This system allows data to be collected on adverse reactions to medicines and vaccines, helping the regulator to track potential risks and take timely measures to protect public health. MedSafetyWeek is an international campaign to raise awareness about medicine safety, conducted annually with the participation of healthcare regulators from different countries. The campaign's goal is to encourage as many people as possible to report adverse effects, as such data enables the identification of rare or previously unknown risks associated with medicine use. The launch of the essay competition is regarded as an additional tool to engage the public in the topic of pharmacovigilance. Participants are invited to share their thoughts on the importance of reporting adverse effects and the role each person plays in ensuring medicine safety. MHRA plans to publish further details about participation conditions, submission deadlines, and evaluation criteria as MedSafetyWeek 2026 approaches.